Repurposing Nitroimidazoles: A New Frontier in Combatting Bacterial Virulence and Quorum Sensing via In Silico, In Vitro, and In Vivo Insights
Drug Development Research · 2025
DOI: 10.1002/ddr.70101 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Development Research, 2025. Verfasst von El-Sayed Khafagy und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia. Hauptthemen laut MEDLINE: Quorum Sensing, Drug Repositioning, Nitroimidazoles, Anti-Bacterial Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 80 Literaturangaben. Gefördert von: The authors extend their appreciation to Prince Sattam bin Abdulaziz University for funding this research work through the project number (PSAU/2024/03/29653)..
Abstract (Originalsprache)
The global antibiotic resistance crisis demands innovative strategies targeting bacterial virulence rather than survival. Quorum sensing (QS), a key regulator of virulence and biofilm formation, offers a promising avenue to mitigate resistance by disarming pathogens without bactericidal pressure. This study investigates the repurposing of nitroimidazoles as anti‐QS and anti‐virulence agents at subminimum inhibitory concentrations (sub‐MICs). In Silico analyses, including molecular docking and molecular dynamics (MD) simulations, were performed to investigate ligand‐receptor interactions with structurally distinct Lux‐type QS receptors and assess binding stability and conformational dynamics over time. In Vitro assays evaluated the effects of representative nitroimidazoles, metronidazole (MET) and secnidazole (SEC), on QS‐controlled phenotypes, including violacein production in Chromobacterium violaceum and biofilm formation and protease activity in Pseudomonas aeruginosa , Acinetobacter baumannii , Salmonella enterica , and Proteus mirabilis . In Vivo efficacy was assessed using a murine infection model and HeLa cell invasion assays. Molecular docking revealed high‐affinity binding to QS receptors, corroborating their mechanistic interference. Sub‐MIC MET/SEC significantly suppressed violacein synthesis, biofilm biomass, and protease secretion in Gram‐negative pathogens. Both compounds reduced bacterial invasiveness in HeLa cells and In Vivo protected mice from lethal P. aeruginosa infections. Crucially, nitroimidazoles attenuated virulence without affecting bacterial viability, preserving microbial ecology. These findings position nitroimidazoles as dual‐function agents; antimicrobial at bactericidal doses and anti‐virulence at sub‐MICs. Their validated efficacy across In Silico, In Vitro, and In Vivo models underscores their potential as adjunctive therapies, bridging the gap between drug repurposing and next‐generation anti‐infective development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia.
- Department of Pharmaceutics, College of Pharmacy, University of Ha'il, Ha'il, Saudi Arabia.
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.
- Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Zagazig University, Zagazig, Egypt.
- Department of Microbiology and Immunology, Faculty of Pharmacy, Zagazig University, Zagazig, Egypt.
- Department of Pharmaceutical Sciences, Pharmacy Program, Oman College of Health Sciences, Muscat, Oman.
ORCID-Profile: Bjad K Almutairy, Tarek S Ibrahim, Wael A H Hegazy
Förderung
- The authors extend their appreciation to Prince Sattam bin Abdulaziz University for funding this research work through the project number (PSAU/2024/03/29653).
Zitieren
APA
Khafagy, E. S., Saqr, A. A., Almutairy, B. K., Aldawsari, M. F., Lila, A. S. A., Ibrahim, T. S., Hegazy, W. A. H., & Salem, I. M. (2025). Repurposing Nitroimidazoles: A New Frontier in Combatting Bacterial Virulence and Quorum Sensing via In Silico, In Vitro, and In Vivo Insights. Drug Development Research. https://doi.org/10.1002/ddr.70101
Vancouver
Khafagy ES, Saqr AA, Almutairy BK, Aldawsari MF, Lila ASA, Ibrahim TS, et al. Repurposing Nitroimidazoles: A New Frontier in Combatting Bacterial Virulence and Quorum Sensing via In Silico, In Vitro, and In Vivo Insights. Drug Development Research. 2025. doi:10.1002/ddr.70101
BibTeX
@article{Khafagy2025,
author = {Khafagy, El-Sayed and Saqr, Ahmed Al and Almutairy, Bjad K and Aldawsari, Mohammed F and Lila, Amr Selim Abu and Ibrahim, Tarek S and Hegazy, Wael A H and Salem, Ibrahim M},
title = {Repurposing Nitroimidazoles: A New Frontier in Combatting Bacterial Virulence and Quorum Sensing via In Silico, In Vitro, and In Vivo Insights},
journal = {Drug Development Research},
year = {2025},
doi = {10.1002/ddr.70101}
}
EUVIMED